Navigation Links
Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer
Date:7/3/2012

SF3B1 gene, which have been shown to be associated with chemotherapy response in CLL (chronic lymphocytic leukemia) patients.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Trovagene's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; limited sales and marketing efforts and dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any medical diagnostic tests under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical trials discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. Trovagene does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in Trovagene's Form 10-K for the year ended December 31, 2011 and other periodic reports filed with the Securities and Exchange Commission.

Contacts
Trovagene, Inc.
Keith McCormick
VP, Commercial Operations
+1 (858) 952-7640
kmccormick@trovagene.com
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
2. Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine
3. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
4. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
5. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
6. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
7. Shingles Vaccine is Safe, According to New Study
8. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014 Using publicly released ... health plan costs for five common specialty drugs. ... consumers given their high costs and shortage of ... cost thousands per prescription, and are used for ... and multiple sclerosis. HealthPocket found ...
(Date:8/26/2014)... 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and its associated ... to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 ... affects more than 100,000 Americans. As this disease ... gradually lose the ability to breathe, leading ultimately ...
(Date:8/26/2014)... NEW YORK and LONDON ...   FDNA Inc. ( http://www.fdna.com ) ... today that they have partnered to offer, for the ... exclusively through FDNA,s solutions. FDNA, developer of ... fully integrate LMD,s award-winning collection into Face2Gene [ ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
... ATLANTA, June 7, 2011 CardioMEMS, Inc ., an ... a proprietary wireless sensing and communication technology for the human ... Yadav, M.D. , is a finalist for the 25th annual ... Entrepreneur category. The awards are sponsored by the Metro Atlanta ...
... June 7, 2011 The ALS Therapy Development Institute ... Michael Capuano (D-MA) with its first ever "Lou Gehrig ... gala event this November 3rd.  The award recognizes ... advocate for additional funding for research leading to an ...
Cached Medicine Technology:Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 2Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award 3U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS TDI During Gala Event this November 2
(Date:8/27/2014)... 2014 PCOS (Polycystic Ovarian Syndrome) affects ... at risk for a number of health disorders and ... well understood even within the medical community. Many women ... (hirsutism) and excess body fat around the waist area ... problems are caused by PCOS. , Awareness is the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... PartnerTech AB, a major systems integration and electronics ... Cryotherapy offering the first U.S. designed and ... offered the ideal combination of manufacturing expertise, location, ... system. Impact Cryotherapy, headquartered in Atlanta, GA, offers ...
(Date:8/27/2014)... DeLand, FL (PRWEB) August 27, 2014 *Anyone who ... in DeLand, FL can visit Avail Clinical Research on the web ... Fibromyalgia , Over 5 million Americans are affected by fibromyalgia – ... such as:, Chronic widespread pain , ... Chronic fatigue and sleep problems , Depression , ...
(Date:8/26/2014)... Co (PRWEB) August 27, 2014 Carol ... new cookbook— 100 Best Quick Gluten-Free Recipes (Houghton ... gluten-free meals. , Fenster believes that cooking gluten-free ... understands how today’s busy lifestyle doesn’t leave much time ... that gluten-free cooks ask me is how to shorten ...
(Date:8/26/2014)... Wauwatosa, WI (PRWEB) August 27, 2014 AlignLife ... the month of July. "We had a goal to collect ... Force", Dr. Sara Mahalko said. "Our patients helped us not ... our goal." AlignLife of Wauwatosa collected 559lbs of ... the bar high for next year," explains Dr. Katie Sam. ...
Breaking Medicine News(10 mins):Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 2Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 3Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 2Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 3Health News:AlignLife Wauwatosa Thanksgiving in July Yields over 500 lbs of Food 2
... that are commonly referred to as non-communicable diseases could cause ... of the health care cost by 2015, according to estimates ... million people in 2005 to NCD, the toll might reach ... Robert Beaglehole, director of NCD, WHO. ,He was ...
... Pradesh, 136 have been found to be due to ... announced this shocking report in the Assembly. ... identify individuals/health organizations involved in the controversial blood transfusion ... would be implemented to avoid such instances in the ...
... Birth under the Guangdong Family Planning Research Institute in ... discovered 39 cases of new abnormal chromosomes. // ... scientists for genetic and cloning researches. ,Director ... these cases of abnormal chromosomes have been verified by ...
... AIDS/HIV, which is haunting the world for over two decades ... countries in the Asia Pacific // Region would meet in ... treatment and prevention would be the main focus of the ... target to expand AIDS treatment to over 3 million universal ...
... the second leading cause of blindness, worldwide would affect 60 ... end of 2020, // based on a projection in the ... and Africa would be the worst affected by the disabling ... of all glaucoma cases by then. Six out of ...
... treat pneumonia, bronchitis and other infections. Bristol-Myers Squibb Co. ... U.S. Food and Drug Administration said that the drug ... from blood-sugar changes due to this drug. ... of serious cases of hypoglycemia (low blood sugar) and ...
Cached Medicine News:
Athouritative, on the spot answers for acute care and consultations....
The workhorse electric system....
... Knife with BD Xstar Blade includes a ... the blade in prodedure and handling. ... a grind-less process for manufacturing surgical blades. ... and consistency. The arch style, single-bevel ...
... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...
Medicine Products: